ABN AMRO Bank NV (LTS:0RDM)

€ 15.04 -0.0425 (-0.28%) Market Cap: 12.48 Bil Enterprise Value: 58.55 Bil PE Ratio: 5.21 PB Ratio: 0.48 GF Score: 62/100

Q3 2024 ABN Amro Bank NV Earnings Call Transcript
Nov 13, 2024

€15.03 (-2.16%)

Earnings
Q2 2024 ABN Amro Bank NV Earnings Call Transcript
Aug 07, 2024

€15.28 (+5.91%)

Earnings
ABN Amro Bank NV at Morgan Stanley European Financials Conference Transcript
Mar 13, 2024
Q4 2023 ABN Amro Bank NV Earnings Call Transcript
Feb 14, 2024

€14.41 (+6.09%)

Earnings
Q3 2023 ABN Amro Bank NV Earnings Call Transcript
Nov 08, 2023

€11.95 (-8.30%)

Earnings
Q2 2023 ABN Amro Bank NV Earnings Call Transcript
Aug 09, 2023

€14.32 (-2.96%)

Earnings
ABN Amro Bank NV at Goldman Sachs European Financials Conference Transcript
Jun 14, 2023
Q1 2023 ABN Amro Bank NV Earnings Call Transcript
May 10, 2023

€13.83 (-2.61%)

Earnings
Q4 2022 ABN Amro Bank NV Earnings Call Transcript
Feb 08, 2023

€16.22 (+12.04%)

Earnings
Q3 2022 ABN Amro Bank NV Earnings Call Transcript
Nov 09, 2022

€10.98 (+4.10%)

Earnings
Q2 2022 ABN Amro Bank NV Earnings Call Transcript
Aug 10, 2022

€10.03 (-1.62%)

Earnings
ABN Amro Bank NV at Goldman Sachs European Financials Conference Transcript
Jun 09, 2022
Q1 2022 ABN Amro Bank NV Earnings Call Transcript
May 18, 2022

€10.55 (-10.80%)

Earnings
ABN Amro Bank NV Annual Shareholders Meeting Transcript
Apr 20, 2022
ABN Amro Bank NV Extraordinary Shareholders Meeting Transcript
Feb 17, 2022
Q4 2021 ABN Amro Bank NV Earnings Call Transcript
Feb 09, 2022

€13.99 (-7.81%)

Earnings
ABN Amro Bank NV Extraordinary Shareholders Meeting Transcript
Nov 24, 2021
Q3 2021 ABN Amro Bank NV Earnings Call Transcript
Nov 10, 2021

€13.04 (+2.32%)

Earnings
Q2 2021 ABN Amro Bank NV Earnings Call Transcript
Aug 11, 2021

€11.54 (+8.38%)

Earnings
Q1 2021 ABN Amro Bank NV Earnings Call Transcript
May 12, 2021

€10.34 (-6.03%)

Earnings
ABN Amro Bank NV Annual Shareholders Meeting Transcript
Apr 21, 2021
Q4 2020 ABN Amro Bank NV Earnings Call Transcript
Feb 10, 2021

€8.46 (-0.35%)

Earnings
ABN Amro Bank NV Extraordinary Shareholders Meeting Transcript
Dec 15, 2020
Novartis AG, ABN Amro Bank NV & BlackRock Inc at Novartis Co-Creating Impact Summit (Virtual) - PM Session Transcript
Dec 09, 2020
ABN Amro Bank NV Virtual Investor Update 2020 Transcript
Nov 30, 2020
Q3 2020 ABN Amro Bank NV Earnings Call Transcript
Nov 11, 2020

€8.25 (-4.46%)

Earnings
ABN Amro Bank NV at Bank of America Merrill Lynch Financials CEO Conference (Virtual) Transcript
Sep 24, 2020
Q2 2020 ABN Amro Bank NV Earnings Call Transcript
Aug 12, 2020

€8.61 (+8.07%)

Earnings
Q1 2020 ABN Amro Bank NV Earnings Call Transcript
May 13, 2020

€6.15 (-7.49%)

Earnings
ABN Amro Bank NV Annual Shareholders Meeting Transcript
Apr 22, 2020
ABN Amro Bank NV at Morgan Stanley European Financials Conference Transcript
Mar 17, 2020
Q4 2019 ABN Amro Bank NV Earnings Call Transcript
Feb 12, 2020

€15.93 (-4.34%)

Earnings
ABN Amro Bank NV Extraordinary Shareholders Meeting Transcript
Dec 17, 2019
Q3 2019 ABN Amro Bank NV Earnings Call Transcript
Nov 13, 2019

€16.75 (-4.00%)

Earnings
Q2 2019 ABN Amro Bank NV Earnings Call Transcript
Aug 07, 2019

€16.45 (-1.16%)

Earnings
Q1 2019 ABN AMRO Group NV Earnings Call Transcript
May 15, 2019

€19.35 (+0.99%)

Earnings
ABN AMRO Group NV Annual Shareholders Meeting Transcript
Apr 24, 2019
Q4 2018 ABN AMRO Group NV Earnings Call Transcript
Feb 13, 2019

€20.42 (-6.71%)

Earnings

Q2 2020 ABN Amro Bank NV Earnings Call Transcript

Aug 12, 2020 / 09:00AM GMT

Release Date Price: €8.61 (+8.07%)

Transcript

Operator

Ladies and gentlemen, welcome to this ABN AMRO Second Quarter 2020 Analyst and Investor Call. (Operator Instructions) Following the presentation, we will conduct the question-and-answer session.

I would now like to hand the call over to Mr. Robert Swaak, CEO of ABN AMRO. Please go ahead, sir.

Robert Swaak

ABN AMRO Bank N.V. - CEO & Chairman of Management Board

Thank you very much, and good morning, everyone. Thanks for joining our investors and analyst call. I'm joined by Clifford Abrahams, our CFO; and Tanja Cuppen, our CRO. I'm looking forward to sharing my views with you on our progress on strategy and the outcome of the CIB review, as I promised to you earlier.

Clifford will go through the details of the first quarter results and run you through -- sorry, made a mistake there. He will run you, that's on me, run you through the details of the second quarter results and run you through capital. Tanja will update you on developments in our loan portfolio, including Q2 impairments, and our latest guidance on full year 2020 cost of risk.

Already have an account? Log in

Get the full story

Start 7-Day Free Trial

	Access to All Earning Calls and Stock Analysis
	30-Year Financial on one screen
	All-in-one Stock Screener with unlimited filters
	Customizable Stock Dashboard
	Real Time Insider Trading Transactions
	8,000+ Institutional investors’ 13F holdings
	Powerful Excel Add-in and Google sheets Add-on
	All data downloadable
	Quick customer support
	And much more...

30-Day 100% money back guarantee

You are not charged until the trial ends. Subscription fee may be tax deductible.

Excellent

4.6 out of 5

Trustpilot

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Mobile App 中文

Education

Financial Glossary Tutorials FAQ Schedule Free Session Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Site Map Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.